# TRIESENCE
> **NDA022223** · New Drug Application · Sponsor: ALCON RES · Approved 2007-11-29
## Drug
- **FDA Application Number:** NDA022223
- **Application type:** New Drug Application
- **Brand name:** TRIESENCE
- **Generic name:** Triamcinolone Acetonide
- **Active ingredients:** TRIAMCINOLONE ACETONIDE
- **Dosage form:** INJECTABLE
- **Route:** SUSPENSION
- **Marketing status:** Prescription
- **Sponsor:** ALCON RES
- **First approval:** 2007-11-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022223)
---
*MORVS · CC0 1.0*